{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:03:15Z","timestamp":1787320995958,"version":"build-2736575974"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,4,20]]},"DOI":"10.18632\/aging.103036","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:45:34Z","timestamp":1587386734000},"page":"6756-6773","source":"Crossref","is-referenced-by-count":47,"title":["Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B"],"prefix":"10.18632","volume":"12","author":[{"given":"Jun","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Dental Implantology, Jinan Stomatological Hospital, Jinan 250001, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan 250014, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oral Disease Gaoxin Branch, Jinan Stomatological Hospital, Jinan 250001, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oral Disease Gaoxin Branch, Jinan Stomatological Hospital, Jinan 250001, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oral Disease Gaoxin Branch, Jinan Stomatological Hospital, Jinan 250001, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinji","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Oral Disease Gaoxin Branch, Jinan Stomatological Hospital, Jinan 250001, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007.","volume":"5","author":"Thun","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.oraloncology.2010.02.002","article-title":"MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.","volume":"4","author":"Zhang","year":"2010","journal-title":"Oral Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2174\/1568026043387746","article-title":"Growth factor signaling and resistance to cancer chemotherapy.","volume":"4","author":"Sad\u00e9e","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"4","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1002\/cncr.26560","article-title":"MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.","volume":"11","author":"Chen","year":"2012","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3892\/or.2015.3866","article-title":"miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.","volume":"3","author":"Yue","year":"2015","journal-title":"Oncol Rep"},{"key":"6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/aps.2010.48","article-title":"Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.","volume":"3","author":"Ma","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcrt.JCRT_763_17","article-title":"Mechanisms correlated with chemotherapy resistance in tongue cancers.","volume":"1","author":"Yu","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1091\/mbc.10.4.947","article-title":"Taxol suppresses dynamics of individual microtubules in living human tumor cells.","volume":"1","author":"Jordan","year":"1999","journal-title":"Mol Biol Cell"},{"key":"9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0955-0674(02)00382-4","article-title":"Regulation of APC-Cdc20 by the spindle checkpoint.","volume":"1","author":"Yu","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/CAD.0000000000000451","article-title":"Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.","volume":"2","author":"Huang","year":"2017","journal-title":"Anticancer Drugs"},{"key":"11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/aps.2013.35","article-title":"Friend or foe: the role of microRNA in chemotherapy resistance.","volume":"3","author":"Yang","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd3870","article-title":"The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.","volume":"1","author":"Mitsiades","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2014vesicular carriers for intercellular communication.","volume":"2","author":"Raposo","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00441-012-1428-2","article-title":"Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.","volume":"35","author":"Simons","year":"2013","journal-title":"Cell Tissue Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in Cancer.","volume":"6","author":"Croce","year":"2009","journal-title":"Annu Rev Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer.","volume":"6","author":"Slack","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","article-title":"How microRNAs control cell division, differentiation and death.","volume":"1","author":"Miska","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer.","volume":"9","author":"Croce","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.biopha.2017.04.006","article-title":"miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21.","volume":"9","author":"Deng","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.toxlet.2015.11.009","article-title":"miRNA-200c mediates mono-butyl phthalate-disrupted steroidogenesis by targeting vimentin in Leydig tumor cells and murine adrenocortical tumor cells.","volume":"24","author":"Wang","year":"2016","journal-title":"Toxicol Lett"},{"key":"21","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/stem.1448","article-title":"MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1.","volume":"3","author":"Xiao","year":"2013","journal-title":"Stem Cells"},{"key":"22","first-page":"193","article-title":"MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.","volume":"10","author":"Huang","year":"2015","journal-title":"Minerva Med"},{"key":"23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/mmr.2013.1403","article-title":"miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN\/Akt signaling.","volume":"7","author":"Liu","year":"2013","journal-title":"Mol Med Rep"},{"key":"24","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","article-title":"Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.","volume":"8","author":"Allgayer","year":"2010","journal-title":"Mol Cancer Res"},{"key":"25","first-page":"6533","article-title":"MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.","volume":"8","author":"Luo","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1476-4598-10-126","article-title":"Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.","volume":"1","author":"Watson","year":"2011","journal-title":"Mol Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.","volume":"2","author":"Cordon-Cardo","year":"2012","journal-title":"Cancer Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00109-016-1420-5","article-title":"miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.","volume":"9","author":"\u015eahin","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"29","doi-asserted-by":"publisher","first-page":"821717","DOI":"10.1155\/2010\/821717","article-title":"Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.","volume":"201","author":"Richer","year":"2010","journal-title":"J Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1158\/1078-0432.CCR-10-2532","article-title":"Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.","volume":"1","author":"Doki","year":"2011","journal-title":"Clin Cancer Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0002-9610(97)00282-1","article-title":"Clinicopathological analysis of local spread of carcinoma of the tongue.","volume":"17","author":"Lam","year":"1998","journal-title":"Am J Surg"},{"key":"32","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.4161\/cc.5.17.3133","article-title":"Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR.","volume":"5","author":"Brock","year":"2006","journal-title":"Cell Cycle"},{"key":"33","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.18632\/oncotarget.3052","article-title":"The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.4267\/2042\/56438","article-title":"MIR200C (microRNA 200c).","author":"Sahin","year":"2015","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.18632\/oncotarget.1427","article-title":"The proto-oncogene KRAS is targeted by miR-200c.","volume":"5","author":"Roidl","year":"2014","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1158\/1535-7163.MCT-14-0167","article-title":"miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2\/c-Jun signaling pathway in colorectal cancer.","volume":"1","author":"Li","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"37","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1158\/1535-7163.MCT-08-1046","article-title":"MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.","volume":"8","author":"Richer","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"38","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-12-0463","article-title":"Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.","volume":"1","author":"Richer","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"39","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.ajpath.2012.07.009","article-title":"miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.","volume":"18","author":"Xu","year":"2012","journal-title":"Am J Pathol"},{"key":"40","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1242\/jcs.02552","article-title":"Epithelial-mesenchymal transition.","volume":"11","author":"Radisky","year":"2005","journal-title":"J Cell Sci"},{"key":"41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression.","volume":"1","author":"Beug","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression.","volume":"1","author":"Berx","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.","volume":"9","author":"Brabletz","year":"2008","journal-title":"EMBO Rep"},{"key":"44","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","article-title":"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.","volume":"1","author":"Bonner","year":"2000","journal-title":"Curr Biol"},{"key":"45","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/jnci\/djr326","article-title":"mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.","volume":"10","author":"Taron","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1582-4934.2009.00964.x","article-title":"Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).","volume":"1","author":"Long-Bang","year":"2010","journal-title":"J Cell Mol Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.2147\/IJN.S70919","article-title":"Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.","volume":"9","author":"Bi","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2017.03.001","article-title":"MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.","volume":"33","author":"Lu","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2407-13-72","article-title":"MiR-200c and HuR in ovarian cancer.","volume":"1","author":"Ferlini","year":"2013","journal-title":"BMC Cancer"},{"key":"50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","article-title":"A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.","volume":"184","author":"Duroux","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"51","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.","volume":"54","author":"Kalluri","year":"2017","journal-title":"Nature"},{"key":"52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/17425247.2.2.237","article-title":"Cationic liposomes for gene delivery.","volume":"2","author":"de Lima","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"53","doi-asserted-by":"publisher","first-page":"e95240","DOI":"10.1371\/journal.pone.0095240","article-title":"Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS One"},{"key":"54","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ymthe.2018.01.001","article-title":"Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer.","volume":"2","author":"Ba","year":"2018","journal-title":"Mol Ther"},{"key":"55","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/mtna.2013.60","article-title":"Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity.","volume":"2","author":"Rameshwar","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"56","doi-asserted-by":"publisher","first-page":"42339","DOI":"10.1038\/srep42339","article-title":"MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma.","volume":"7","author":"Tanemura","year":"2017","journal-title":"Sci Rep"},{"key":"57","doi-asserted-by":"publisher","first-page":"864894","DOI":"10.1155\/2014\/864894","article-title":"Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.","volume":"201","author":"Song","year":"2014","journal-title":"Biomed Res Int"},{"key":"58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.","volume":"2","author":"Kuroda","year":"2013","journal-title":"Mol Ther"},{"key":"59","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s13277-014-2807-y","article-title":"Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer.","volume":"3","author":"Guo","year":"2015","journal-title":"Tumour Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2013.10.025","article-title":"miRNA-205 affects infiltration and metastasis of breast cancer.","volume":"44","author":"Ren","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"61","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"2","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"62","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq.","volume":"2","author":"Salzberg","year":"2009","journal-title":"Bioinformatics"},{"key":"63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-3167-5_18","article-title":"Analysis of RNA-Seq Data Using TopHat and Cufflinks.","volume":"137","author":"Chan","year":"2016","journal-title":"Methods Mol Biol"},{"key":"64","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis.","volume":"9","author":"Eliceiri","year":"2012","journal-title":"Nat Methods"}],"updated-by":[{"DOI":"10.18632\/aging.206148","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"record-id":"58678"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:16:47Z","timestamp":1599063407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,30]]}},"alternative-id":["103036","32310826"],"URL":"https:\/\/doi.org\/10.18632\/aging.103036","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}